Metabolic Dysfunction–Associated Steatotic Liver Disease in Pregnancy: A Review
Further research is needed to demonstrate optimal screening, diagnosis, and management in pregnancy. If detected early, early diabetes screening and low-dose aspirin may be appropriate, given the significant association with gestational diabetes and gestational hypertensive disorders. Patients should be counseled on the increased risk of maternal morbidity, preterm birth, miscarriage, macrosomia, pregnancy-induced hypertension, cesarean delivery, gestational diabetes, and metabolic disease in the offspring.
Authors
- M. J. Mahoney
- Christopher Menefee
- Daniel Core
- Daniel Lewis (ORCID: https://orcid.org/0000-0003-1750-4355)
- Layne Landry
- Shruti Vaidyanathan
Institutions
- Dynavax Technologies (Germany) (DE)
- Louisiana State University Health Sciences Center Shreveport (US)
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1097/ogx.0000000000001481
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00